Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Cancer Research and Treatment|July 19, 2024
Recent Advances in Genomic Approaches for the Detection of Homologous Recombination DeficiencyYoo-Na Kim, Doga C Gulhan, Hu Jin, et al.Nature Communications|March 23, 2021
The origins and genetic interactions of KRAS mutations are allele- and tissue-specificJoshua H Cook, Giorgio E M Melloni, Doga C Gulhan, et al.Nature Reviews. Genetics|December 9, 2021
Computational analysis of cancer genome sequencing dataIsidro Cortés-Ciriano, Doga C Gulhan, Jake June-Koo Lee, et al.Nature Genetics|February 16, 2024
Accurate and sensitive mutational signature analysis with MuSiCalHu Jin, Doga C Gulhan, Benedikt Geiger, et al.Nature Genetics|April 17, 2019
Detecting the mutational signature of homologous recombination deficiency in clinical samplesDoga C Gulhan, Jake June-Koo Lee, Giorgio E M Melloni, et al.Genome Medicine|December 19, 2023
De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing dataTianyun Zhang, Hanying Jia, Tairan Song, et al.Cancer Cell|January 30, 2026
Emerging landscape of KRAS inhibitors in cancer treatmentJakob M Riedl, Hiroyuki Matsubara, Reid McNeil, et al.Biorxiv : the Preprint Server for Biology|May 4, 2026
Topographical archetypes of somatic mutagenesis in cancerAllen W Lynch, Sangmi Sandra Lee, Jan P Hummel, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumorsDoga C Gulhan, David Barras, Marco Mina, et al.The Prostate|September 10, 2024
A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancerDaniel Boiarsky, Alok K Tewari, Doga C Gulhan, et al.Pageof 4